ID   G523
AC   CVCL_B4P6
SY   G523NS
DR   EGA; EGAS00001003493
DR   EGA; EGAS00001003700
DR   GEO; GSM3439929
DR   GEO; GSM3439930
DR   GEO; GSM3439931
DR   GEO; GSM3439938
DR   GEO; GSM3439939
DR   GEO; GSM3439940
DR   Wikidata; Q110432806
RX   DOI=10.1021/acsmaterialsau.3c00029;
RX   PubMed=31249064;
RX   PubMed=30995489;
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Omics: CTCF ChIP-seq epigenome analysis.
CC   Omics: H3K27ac ChIP-seq epigenome analysis.
CC   Omics: Hi-C chromosome conformation analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
RX   DOI=10.1021/acsmaterialsau.3c00029;
RA   Smith L.J., Skirzynska A., Chin A.A., Arnold A.E., Kushida M.M.,
RA   Dirks P.B., Shoichet M.S.;
RT   "Engineered in vitro tumor model recapitulates molecular signatures of
RT   invasion in glioblastoma.";
RL   ACS Materials Au 3:514-527(2023).
//
RX   PubMed=31249064; DOI=10.1101/gr.246520.118;
RA   Johnston M.J., Nikolic A., Ninkovic N., Guilhamon P., Cavalli F.M.G.,
RA   Seaman S., Zemp F.J., Lee J., Abdelkareem A., Ellestad K., Murison A.,
RA   Kushida M.M., Coutinho F.J., Ma Y., Mungall A.J., Moore R.,
RA   Marra M.A., Taylor M.D., Dirks P.B., Pugh T.J., Morrissy A.S.,
RA   St Croix B., Mahoney D.J., Lupien M., Gallo M.;
RT   "High-resolution structural genomics reveals new therapeutic
RT   vulnerabilities in glioblastoma.";
RL   Genome Res. 29:1211-1222(2019).
//
RX   PubMed=30995489; DOI=10.1016/j.celrep.2019.03.047;
RA   MacLeod G., Bozek D.A., Rajakulendran N., Monteiro V., Ahmadi M.,
RA   Steinhart Z., Kushida M.M., Yu H., Coutinho F.J., Cavalli F.M.G.,
RA   Restall I.J., Hao X.-G., Hart T., Luchman H.A., Weiss S., Dirks P.B.,
RA   Angers S.;
RT   "Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and
RT   mechanisms of temozolomide sensitivity in glioblastoma stem cells.";
RL   Cell Rep. 27:971-986.e9(2019).
//
RX   PubMed=36989359; DOI=10.1126/sciadv.ade5321;
RA   Wang X., Gong Z.-Y., Wang T.-C., Law J.-H., Chen X., Wanggou S.-Y.,
RA   Wang J.-T., Ying B.-B., Francisco M.A., Dong W.-F., Xiong Y., Fan J.J.,
RA   MacLeod G., Angers S., Li X.-J., Dirks P.B., Liu X.-Y., Huang X.,
RA   Sun Y.;
RT   "Mechanical nanosurgery of chemoresistant glioblastoma using
RT   magnetically controlled carbon nanotubes.";
RL   Sci. Adv. 9:eade5321.1-eade5321.14(2023).
//